Supramolecular self-assembled nanoparticles mediate oral delivery of therapeutic TNF-α siRNA against systemic inflammation.
作者信息
Yin Lichen, Song Ziyuan, Qu Qiuhao, Kim Kyung Hoon, Zheng Nan, Yao Catherine, Chaudhury Isthier, Tang Haoyu, Gabrielson Nathan P, Uckun Fatih M, Cheng Jianjun
机构信息
Department of Materials Science and Engineering, University of Illinois, Urbana-Champaign, 1304 West Green Street, Urbana, IL 61801, USA.
出版信息
Angew Chem Int Ed Engl. 2013 May 27;52(22):5757-61. doi: 10.1002/anie.201209991. Epub 2013 Apr 22.
Abstract
摘要
相似文献
1
Supramolecular self-assembled nanoparticles mediate oral delivery of therapeutic TNF-α siRNA against systemic inflammation.
Angew Chem Int Ed Engl. 2013 May 27;52(22):5757-61. doi: 10.1002/anie.201209991. Epub 2013 Apr 22.
2
Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Eur J Pharm Biopharm. 2019 Sep;142:38-48. doi: 10.1016/j.ejpb.2019.06.009. Epub 2019 Jun 11.
3
Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
Nat Mater. 2010 Nov;9(11):923-8. doi: 10.1038/nmat2859. Epub 2010 Oct 10.
4
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
Nanomedicine. 2016 May;12(4):987-1002. doi: 10.1016/j.nano.2015.12.374. Epub 2016 Jan 6.
5
Therapeutic approaches for the delivery of TNF-α siRNA.
Ther Deliv. 2017 Mar;8(5):343-355. doi: 10.4155/tde-2017-0011.
6
Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.
J Gene Med. 2015 Oct-Dec;17(10-12):244-56. doi: 10.1002/jgm.2866.
7
Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate.
J Control Release. 2018 Aug 10;283:280-289. doi: 10.1016/j.jconrel.2018.05.035. Epub 2018 May 31.
8
Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
Acta Biomater. 2015 Apr;17:98-106. doi: 10.1016/j.actbio.2015.01.041. Epub 2015 Feb 7.
9
siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
Acta Biomater. 2020 Feb;103:213-222. doi: 10.1016/j.actbio.2019.12.005. Epub 2019 Dec 6.
10
MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model.
J Control Release. 2012 Aug 10;161(3):772-80. doi: 10.1016/j.jconrel.2012.05.004. Epub 2012 May 11.
引用本文的文献
1
Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities.
J Nanobiotechnology. 2022 Dec 3;20(1):511. doi: 10.1186/s12951-022-01717-x.
2
Oral Delivery of Nucleic Acid Therapies for Local and Systemic Action.
Pharm Res. 2023 Jan;40(1):107-122. doi: 10.1007/s11095-022-03415-7. Epub 2022 Oct 21.
3
Advances in oral peptide drug nanoparticles for diabetes mellitus treatment.
Bioact Mater. 2022 Feb 28;15:392-408. doi: 10.1016/j.bioactmat.2022.02.025. eCollection 2022 Sep.
4
Targeting the Gut Mucosal Immune System Using Nanomaterials.
Pharmaceutics. 2021 Oct 21;13(11):1755. doi: 10.3390/pharmaceutics13111755.
5
TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
J Control Release. 2018 Oct 10;287:235-246. doi: 10.1016/j.jconrel.2018.08.021. Epub 2018 Aug 11.
6
Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-based metastable nanoparticles.
Nanoscale. 2018 Aug 16;10(32):15339-15349. doi: 10.1039/c8nr03976c.
7
Nanocapsule-mediated cytosolic siRNA delivery for anti-inflammatory treatment.
J Control Release. 2018 Aug 10;283:235-240. doi: 10.1016/j.jconrel.2018.06.001. Epub 2018 Jun 5.
8
Knockdown of TNF‑α alleviates acute lung injury in rats with intestinal ischemia and reperfusion injury by upregulating IL‑10 expression.
Int J Mol Med. 2018 Aug;42(2):926-934. doi: 10.3892/ijmm.2018.3674. Epub 2018 May 14.
9
Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.
Proc Natl Acad Sci U S A. 2018 May 8;115(19):4903-4908. doi: 10.1073/pnas.1712963115. Epub 2018 Apr 23.
10
Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.
Sci Rep. 2018 Feb 1;8(1):2178. doi: 10.1038/s41598-018-20632-6.
本文引用的文献
1
A bioreducible polymer for efficient delivery of Fas-silencing siRNA into stem cell spheroids and enhanced therapeutic angiogenesis.
Angew Chem Int Ed Engl. 2012 Nov 19;51(47):11899-903. doi: 10.1002/anie.201206595. Epub 2012 Oct 16.
2
Multifunctional hybrid nanoconjugates for efficient in vivo delivery of immunomodulating oligonucleotides and enhanced antitumor immunity.
Angew Chem Int Ed Engl. 2012 Sep 17;51(38):9670-3. doi: 10.1002/anie.201204989. Epub 2012 Aug 22.
3
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo.
Angew Chem Int Ed Engl. 2012 Aug 20;51(34):8529-33. doi: 10.1002/anie.201203263. Epub 2012 Jul 10.
4
Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment.
Angew Chem Int Ed Engl. 2012 Jul 16;51(29):7203-7. doi: 10.1002/anie.201201390. Epub 2012 Jun 13.
5
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery.
Nat Nanotechnol. 2012 Jun 3;7(6):389-93. doi: 10.1038/nnano.2012.73.
6
Self-assembled RNA interference microsponges for efficient siRNA delivery.
Nat Mater. 2012 Feb 26;11(4):316-22. doi: 10.1038/nmat3253.
7
Comparative study of nanoparticle-mediated transfection in different GI epithelium co-culture models.
J Control Release. 2012 May 30;160(1):48-56. doi: 10.1016/j.jconrel.2012.01.041. Epub 2012 Feb 3.
8
Efficient suppression of murine intracellular adhesion molecule-1 using ultrasound-responsive and mannose-modified lipoplexes inhibits acute hepatic inflammation.
Hepatology. 2012 Jul;56(1):259-69. doi: 10.1002/hep.25607. Epub 2012 Jun 6.
9
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Adv Drug Deliv Rev. 2012 May 1;64(6):557-70. doi: 10.1016/j.addr.2011.12.009. Epub 2011 Dec 24.
10
Reactive and bioactive cationic α-helical polypeptide template for nonviral gene delivery.
Angew Chem Int Ed Engl. 2012 Jan 27;51(5):1143-7. doi: 10.1002/anie.201104262. Epub 2011 Dec 7.
Zotero 插件